Drug & intervention
alogliptin 12.5 MG / metformin hydrochloride 1000 MG [Kazano]
RxCUI 1368387
What this record represents
SBDC · RxNormThis is an RxNorm SBDC drug concept. Its name, formulation details and source identifiers are preserved to distinguish it from other drug records.
What this record does not establish: current marketing availability, therapeutic equivalence, safety, or official approval status. Check an up-to-date product label or a pharmacist for product-specific questions.
Related drug records
RxNorm name matchesThese are other published drug concepts with matching brand or formulation names. They are not necessarily equivalent medicines.
KazanoBN · CureCurrent ID 55728
alogliptin / metformin Oral Tablet [Kazano]SBDF · CureCurrent ID 55428
alogliptin 12.5 MG / metformin hydrochloride 500 MG [Kazano]SBDC · CureCurrent ID 55427
alogliptin 12.5 MG / metformin hydrochloride 500 MG Oral Tablet [Kazano]SBD · CureCurrent ID 55429
alogliptin 12.5 MG / metformin hydrochloride 1000 MG Oral Tablet [Kazano]SBD · CureCurrent ID 55425
Advertisement
Active ingredients and chemical structures
RxNorm ingredient relationships. Structures are retrieved by PubChem compound identifier when available. An ingredient can have both a base and a precise salt concept.
Conditions being studied
Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.